首页> 外文期刊>Coronary artery disease >The effects of prior use of atorvastatin on coronary blood flow after primary percutaneous coronary intervention in patients presenting with acute myocardial infarction.
【24h】

The effects of prior use of atorvastatin on coronary blood flow after primary percutaneous coronary intervention in patients presenting with acute myocardial infarction.

机译:急性心肌梗死患者初次经皮冠状动脉介入治疗后,事先使用阿托伐他汀对冠状动脉血流的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Statins exert a variety of favourable effects on the vascular system not directly related to their lipid lowering function known as pleiotropic effects. There are not enough data regarding the effects of prior statin use on coronary blood flow after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI). Accordingly, in the present study, we aimed to investigate the effects of prior statin use on coronary blood flow after primary PCI in patients with AMI using the Thrombolysis In Myocardial Infarction (TIMI) frame count method. METHODS: The study population consisted of 200 patients (161 men; mean age = 62+/-7 years) referred to cardiology clinics with AMI who subsequently underwent successful primary PCI. The study population was divided into two groups according to statin use before primary PCI. Group 1 consisted of 98 patients (75 men; mean age = 63+/-7 years) not taking statin and group 2 consisted of 102 patients (86 men; mean age = 61+/-7 years) taking daily dose of at least 40 mg atorvastatin for at least 6 months. Coronary blood flow was determined by TIMI frame count method using the angiographic images obtained just after PCI and stenting. RESULTS: Only mean TIMI frame count was detected to be significantly lower in patients taking at least 40 mg atorvastatin for at least 6 months compared with that of the patients taking no statin (P<0.001). After confounding variables were controlled for, the mean TIMI frame count of patients in group 2 was significantly lower than that of the patients in group 1 (P=0.001). Pain to balloon time and vessel type were detected as important confounding variables of TIMI frame count after analysis of covariances. CONCLUSIONS: Prior statin use may improve coronary blood flow after PCI in patients with AMI, possibly by its beneficial effects on microvascular function.
机译:背景:他汀类药物对血管系统产生多种有利作用,与它们的降脂功能没有直接关系,称为多效作用。对于急性心肌梗死(AMI)患者,在经皮冠状动脉介入治疗(PCI)后使用他汀类药物对冠脉血流的影响尚无足够数据。因此,在本研究中,我们旨在使用心肌梗塞溶栓(TIMI)框架计数方法研究先前使用他汀类药物对AMI患者原发PCI后冠状动脉血流的影响。方法:研究人群包括200例转诊至AMI心脏病诊所的患者(161名男性,平均年龄= 62 +/- 7岁),随后接受了成功的原发性PCI。根据主要PCI之前他汀类药物的使用,将研究人群分为两组。第一组由98名患者(75名男性;平均年龄= 63 +/- 7岁)不服用他汀类药物组成;第二组由102名患者(86名男性;平均年龄= 61 +/- 7岁)组成,每日剂量至少为40 mg阿托伐他汀至少6个月。冠状动脉血流量通过TIMI帧计数法使用PCI和支架置入后获得的血管造影图像确定。结果:与不服用他汀类药物的患者相比,服用至少40 mg阿托伐他汀至少6个月的患者中仅检测到的TIMI框架计数显着降低(P <0.001)。在控制了混杂变量之后,第2组患者的平均TIMI框架计数显着低于第1组患者的(P = 0.001)。经协方差分析后,发现球囊疼痛时间和血管类型是TIMI帧计数的重要混杂变量。结论:先前使用他汀类药物可改善AMI患者PCI后的冠状动脉血流,可能是由于其对微血管功能的有益作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号